Investigational drug 0524A-032

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Investigational drug 0524A-032, covering 2017-02-17 to 2017-02-17. Get the full timeline:

Most recent: Clinical Trial Update: An Investigational Drug Study Evaluating a Novel Approach to Treat Dyslipidemia (0524A-032) [Phase 2]